IperionX Ltd ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.6MTTM through 31 Dec 2025
Net Income -$35.3MTTM through 31 Dec 2025
Free Cash Flow -$38.8MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | -178.0% |
| Operating Margin | -995.8% |
| Net Margin | -994.4% |
Returns
-32.6%ROE
-27.3%ROA
Balance Sheet Health
Debt / Equity0.04x
Current Ratio4.03x
Net Debt-$61.4Mnet cash position
Cash & Equivalents$65.8M
Quality Metrics
Piotroski F-Score2 / 9
FCF Margin-1,091.9%
Multi-Year Trend
Diluted EPSFY2025: $-0.12
Dividend
No dividend
Capital Allocation
Capex Intensity477.8%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Titan Critical Minerals Project | $0 | View detailsDefinitive Feasibility Study (DFS) funded by the U.S. Department of War is on track for delivery in mid-2026 to establish a domestic source of titanium, rare earths, and zircon. | |
| Titanium Metal Operations | $3.6M | View detailsVirginia Titanium Manufacturing Campus transitioned to 24/7 continuous operations in Q1 2026. Commercial revenues are expected to scale in H2 2026 as customer qualifications progress. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.